Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years

BACKGROUND: To compare visual function and structural improvements in pseudophakic eyes with diabetic macular oedema (DMO) treated with the 0.19mg Fluocinolone Acetonide (FAc) intravitreal implant (Iluvien(TM)) in a ‘real world’ setting. METHODS: A single centre retrospective evaluation of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Fusi-Rubiano, William, Mukherjee, Chandoshi, Lane, Mark, Tsaloumas, Marie D., Glover, Nicholas, Kidess, Andrej, Denniston, Alastair K., Palmer, Helen E., Manna, Avinash, Morjaria, Rupal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389097/
https://www.ncbi.nlm.nih.gov/pubmed/29486754
http://dx.doi.org/10.1186/s12886-018-0726-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389097/
https://www.ncbi.nlm.nih.gov/pubmed/29486754
http://dx.doi.org/10.1186/s12886-018-0726-1

Ejemplares similares